Tim Anderson

Partner, Head of Research

Headshot photo of Tim Anderson

Mr. Anderson is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. Mr. Anderson focuses on investments in biotechnology, diagnostics and digital medicine companies that have the potential to meaningfully address serious medical conditions. He is currently a member of the Board of Directors of Lycia Therapeutics, F2G, Anaveon AG, Autobahn Therapeutics and Scipher Medicines. Mr. Anderson previously served as a Board Member or Board Observer of Vectiv Bio Holdings AG, Therachon Holdings AG, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics.  Prior to his role at Cowen Healthcare Investments, Mr. Anderson was a biotechnology investment banker at Cowen where he worked on a range of financings and mergers and acquisitions.

Mr. Anderson holds a BA in economics from Bowdoin College.

Get In Touch

Start a conversation with Tim Anderson

    Investment Management Team

    Our team of dedicated investment professionals seek to capitalize on disruption and dislocation across market, geographies and sectors.

    View More
    Investment management professional reviews report with a client